Home » News » CROs/Service Providers » GVK partners with Gates Foundation

GVK partners with Gates Foundation

Monday, May 16, 2011

India-based CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.

Under the terms of the agreement, GVK will provide clinical support, logistics, monitoring and project management for trials PDP is conducting in India and Bangladesh.  PDP is a group of non-profit entities partially funded by the Bill and Melinda Gates Foundation.

PDP’s target illnesses include tuberculosis, malaria, HIV, pneumonia and diarrhea which, despite affecting millions of people, are often overlooked by drug companies in favor of conditions that can generate more income. 

Shoibal Mukherjee, senior vice president of clinical development at GVK, said, “GVK Biosciences has been working in the area of neglected diseases for several years, and it is this experience that puts the company in a position to participate in the Global Health Product Development Partners Consortium.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!